- Home
- OBIO vs ALAR Comparison
OBIO vs ALAR Comparison
Compare OBIO & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- ALAR
- Stock Information
- Founded
- OBIO 2017
- ALAR 2013
- Country
- OBIO United States
- ALAR Israel
- Employees
- OBIO N/A
- ALAR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- ALAR Computer Software: Prepackaged Software
- Sector
- OBIO Health Care
- ALAR Technology
- Exchange
- OBIO Nasdaq
- ALAR Nasdaq
- Market Cap
- OBIO 205.0M
- ALAR 70.7M
- IPO Year
- OBIO N/A
- ALAR 2018
- Fundamental
- Price
- OBIO $5.83
- ALAR $18.42
- Analyst Decision
- OBIO Strong Buy
- ALAR Strong Buy
- Analyst Count
- OBIO 4
- ALAR 2
- Target Price
- OBIO $15.75
- ALAR $25.50
- AVG Volume (30 Days)
- OBIO 44.2K
- ALAR 411.2K
- Earning Date
- OBIO 11-11-2024
- ALAR 11-26-2024
- Dividend Yield
- OBIO N/A
- ALAR N/A
- EPS Growth
- OBIO N/A
- ALAR N/A
- EPS
- OBIO N/A
- ALAR 0.07
- Revenue
- OBIO $2,079,000.00
- ALAR $31,117,000.00
- Revenue This Year
- OBIO $7.68
- ALAR $22.15
- Revenue Next Year
- OBIO $110.40
- ALAR $11.59
- P/E Ratio
- OBIO N/A
- ALAR $31.63
- Revenue Growth
- OBIO N/A
- ALAR 52.26
- 52 Week Low
- OBIO $4.22
- ALAR $2.92
- 52 Week High
- OBIO $11.69
- ALAR $46.69
- Technical
- Relative Strength Index (RSI)
- OBIO 60.54
- ALAR 70.31
- Support Level
- OBIO $5.20
- ALAR $17.50
- Resistance Level
- OBIO $5.99
- ALAR $21.50
- Average True Range (ATR)
- OBIO 0.38
- ALAR 1.59
- MACD
- OBIO 0.12
- ALAR 1.21
- Stochastic Oscillator
- OBIO 87.20
- ALAR 75.42
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.